Kaplan-Meier analysis showed a similar pattern for event-free survival at 1 year, with primary stenting only achieving higher freedom from TLR and TVR, major and minor amputation, MI, and death when ...

Following the success of BIOTRONIK's Pulsar-18 0.018"/4F-platform self-expanding stent system, the company has now introduced its Pulsar stent technology in a 0.035"/6F platform.

In the PACUBA trial, a paclitaxel-eluting balloon was associated with significantly higher primary patency at 1 year compared with standard PTA in patients with in-stent restenosis in the ...

At six months, the treatment area of patients who received the stent grafts was more than twice as likely to be functioning compared with patients who received PTA alone (50.6% primary patency ...

Of these patients, 58 underwent PTA alone and 24 underwent PTA with stenting. The stented patients had significantly less residual stenosis post-intervention compared with the angioplasty group (7 ...

PTAS was to be compared with drug treatment with blood-thinning medications alone and with balloon dilatation without stenting (PTA). Like PTAS, PTA always involves administration of blood ...

When compared to standard of care therapy, consisting of either acutely successful PTA or provisional bare stent placement after sub-optimal PTA, the paclitaxel-eluting Zilver stent provides a 45 ...

Patients and Methods: Eighty-seven patients with peripheral occlusive arterial disease stage IIb who had been successfully treated with PTA and stent implantation were randomised to receive orally ...

PTA versus Stenting Several randomized studies, comparing endovascular stenting with stand-alone PTA, demonstrated stenting to be superior in both hemodynamic parameters and Rutherford ...

In their paper published in Circulation in 2016, the Zilver PTX investigators led by Michael D. Dake, MD (University of Arizona, Tucson), reported that the 5-year all-cause mortality rate in the ...

Cordis announces the completion of patient enrollment in SELUTION SLR™ SUCCESS PTA Study PRESS RELEASE PR Newswire Oct. 24, 2023, 08:00 AM ...

This report on the U.S. market for peripheral vascular devices includes peripheral vascular stents, venous stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated ...